Vigil Neuroscience, Inc. engages in the provision of biotechnology research services. Its focus is improving the lives of patients, caregivers, and families affected by neurodegenerative diseases by pursuing the development of disease-modifying therapeutics to restore the vigilance of microglia. The company was founded on June 22, 2020 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
69
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Vigil Neuroscience Inc market cap is $384.23M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Vigil Neuroscience Inc 52 week high is $8.10 as of November 21, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Vigil Neuroscience Inc 52 week low is $1.31 as of November 21, 2026.
Vigil Neuroscience Inc stock price today is $8.06.
Vigil Neuroscience Inc stock price yesterday was $8.05.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Vigil Neuroscience Inc's P/E ratio is -3.85.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Vigil Neuroscience Inc P/B ratio is 9.3047.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Vigil Neuroscience Inc 50-day moving average is $7.99.